Baylor College of Medicine scientists discover a promising cellular mechanism that may offer new treatment targets for neurodegenerative diseases.
Tag: Protein
Tubulin Protein Prevents Toxic Brain Protein Clumps Linked to Alzheimer’s Disease
Scientists identified how tubulin filaments in neurons interact with amyloid and tau proteins potentially delaying the pathological clumping associated with Alzheimer’s.
Scientists Identify NFIL3 Protein That Causes CAR T-Cell Therapy to Lose Effectiveness
A newly identified protein causes engineered immune cells used in cancer treatment to become exhausted pointing to a potential way to improve CAR T therapies.
Whey Protein Manufacturing Technique Could Make Protein Shakes Taste Better and Smoother
A new production method removes bitter minerals from whey protein without sacrificing protein quality making shakes more palatable.
Biodegradable Protein Beads from Food Waste Can Capture Carbon More Efficiently Than Current Tech
Scientists developed protein beads from dairy and tofu waste that can capture carbon dioxide from the atmosphere more efficiently than existing systems.
NFIL3 Protein Causes CAR T-Cell Therapy to Lose Cancer-Fighting Power Over Time
Scientists identify NFIL3 as a major obstacle causing engineered immune cells to become exhausted and stop fighting cancer effectively in patients
New AI model predicts protein structures with unprecedented accuracy
DeepMind’s latest iteration of AlphaFold promises to accelerate drug discovery.
How Protein Traffic Jams in the Brain Lead to Aging and Memory Loss
A breakdown of the Stanford killifish study and its massive implications for Alzheimer’s research.
CLEAR Protein Imaging Technology Showcased at IACS 150th Anniversary Celebrations in India
A new protein visualization technology developed in India was highlighted at a celebration marking 150 years of the Indian Association for the Cultivation of Science.
Gene-Silencing Therapy Safely Lowers LRRK2 Protein in Early Parkinson’s Disease Trial
An experimental therapy targeting the LRRK2 gene safely reduced the relevant protein levels in an early-stage Parkinson’s clinical trial.